When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
TYME - Tyme plans to test TYME-19 as COVID-19 treatment
Tyme Technologies Inc.
Tyme Technologies (TYME+2.1%) has announced to initiate a proof-of-concept Respond trial to investigate its TYME-19 metabolic agent as a therapy against Covid-19.
More news on: Tyme Technologies, Inc., Healthcare stocks news,